Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial

Article

Abstract: Amfepramone (AFP) is an appetite-suppressant drug used in the treatment of obesity. Nonetheless, stu

Palabras claves:

Autores:

Adrián LLerena, de León M.B., Gamino-Peña M.E., Gómez-Silva M., León-Cachón R.B.R., León-García A., Piñeyro-Garza E., Vargas-Zapata R.

Fuentes:

scopus